| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11b6b43c7d7f4b33377f6b7a7b4250e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-33 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b8c058c578c729e6fc4fe57a6bab173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38a0f91ea3a40835c223b1da26bbd78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30871173ea151a1c1443f2bbe237fcf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af257619eb48118a991db25c37fdde99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ed7ddbddad3c53e0aca71bdbee30ab5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_840bc1624c38d7bf36423faff859b263 |
| publicationDate |
2019-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019013203-A2 |
| titleOfInvention |
snap25 antisense oligonucleotides |
| abstract |
The present invention relates to peptide nucleic acid derivatives targeting a 3 'removal site. of the pre-mrna snap25 hu-bro. Peptide nucleic acid derivatives potentially induce at least one variant of human snap25 mRNA removal in cells, and are useful for safely treating dermatological indications or conditions involving the expression of human snap25 protein by topical administration. |
| priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |